DBDaoming Bai

Daoming Bai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daoming Bai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Xu Zhang

    Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China

    3 shared publications
  • Mengyuan Liu

    Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital, Jiangxi Medical College Nanchang University Nanchang Jiangxi China

    2 shared publications
  • Rui Yang

    Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital, Jiangxi Medical College Nanchang University Nanchang Jiangxi China

    2 shared publications
  • Xinyu Huang

    Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College Nanchang University Nanchang China

    2 shared publications
  • Zhiqiang Zhang

    Nanchang University Second Affiliated Hospital

    2 shared publications
  • Chunping Yang

    Nanchang University Second Affiliated Hospital

    1 shared publication

Latest Publications

  • Microplastics in Allergic Rhinitis: Multimechanistic Drivers of Barrier Disruption and Immune Dysregulation

    by Xu Zhang, Zhiqiang Zhang, Mengyuan Liu, Xinyu Huang, Daoming Bai, Rui Yang, Chunping Yang

  • Open Access

    M2 Macrophage Polarization and Its Role in Nasal Diseases: Signaling Pathways and Therapeutic Implications

    by Daoming Bai, Xu Zhang, Zhiqiang Zhang, Mengyuan Liu, Xinyu Huang, Rui Yang, Chunping Yang

    Macrophages—particularly alternatively activated M2 phenotypes—bridge the resolution of inflammation and tissue repair in nasal mucosal disease and allergic airway disorders. Recent advances have delineated a complex signaling architecture governing M2 polarization, including JAK/STAT (STAT6 and STAT3), PI3K/Akt/mTOR, MAPK, Notch, NF-κB, and TGF-β/Smad pathways, along with epigenetic and metabolic circuits. In chronic rhinosinusitis with nasal polyps (CRSwNP), M2 macrophages interact with epithelial and type 2 lymphoid compartments, exhibit defective bactericidal/autophagic functions, and contribute to tissue remodeling through coagulation and damage-associated signals. In allergic rhinitis and asthma, M2 programs orchestrate Th2 amplification, eosinophil recruitment, and airway remodeling, yet can also mediate resolution in appropriate contexts. We synthesize mechanistic insights and disease-specific roles, highlight therapeutic strategies that modulate M2 states, and outline outstanding gaps toward precise macrophage reprogramming in rhinologic disease.

  • Open Access

    Bacterial lysates in allergic rhinitis and chronic rhinosinusitis: Mechanisms and clinical evidence

    by Xinyu Huang, Xu Zhang, Zhiqiang Zhang, Mengyuan Liu, Daoming Bai, Rui Yang, Chunping Yang

    Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are chronic inflammatory disorders of the upper airways with rising global prevalence, contributing significantly to health and socioeconomic burdens. Conventional treatments—including glucocorticoids, antibiotics, antihistamines, and leukotriene inhibitors—remain insufficient in targeting the underlying pathophysiology. Bacterial lysates (BLs), functioning as immunomodulators, activate both innate, and adaptive immune pathways, reestablish Th1/Th2 equilibrium, lower immunoglobulin E concentrations, and attenuate Th2-mediated inflammation. Emerging evidence indicates that BLs (e.g. OM-85, Broncho-Vaxom) markedly improve total nasal symptom scores in AR, suppress Th2 cytokine (IL-4 and IL-13) secretion, and reduce recurrence rates and surgical interventions in CRS. In conjunction with standard therapies, BLs enhance mucosal immune defense and contribute to sustained clinical efficacy. Following the Scale for the Assessment of Narrative Review Articles guidelines, this review critically evaluates the composition, manufacturing processes, immunoregulatory mechanisms, and clinical progress of BLs in AR and CRS, providing a conceptual framework for their clinical application.